AGRX - Agile Therapeutics GAAP EPS of -$0.10 beats by $0.12 revenue of $4M beats by $0.87M
2023-03-22 16:53:27 ET
- Agile Therapeutics press release ( NASDAQ: AGRX ): Q4 GAAP EPS of -$0.10 beats by $0.12 .
- Revenue of $4M (+164.9% Y/Y) beats by $0.87M .
- Shares +31.14% .
For further details see:
Agile Therapeutics GAAP EPS of -$0.10 beats by $0.12, revenue of $4M beats by $0.87M